ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,950Medicare Part D Prescriptions Filled, Including Refills
$969K Total Retail Price of All Prescriptions
471 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 539 377
HYDROCODONE-ACETAMINOPHEN 472 255 S3
FUROSEMIDE 411 318
LEVOTHYROXINE SODIUM 385 278
SIMVASTATIN 349 231
OMEPRAZOLE 309 229
METFORMIN HCL 284 172
CLOPIDOGREL 240 206
METOPROLOL TARTRATE 234 179
NEXIUM 229 154
HYDROCHLOROTHIAZIDE 213 163
ZETIA 208 135
CARVEDILOL 200 178
AMLODIPINE BESYLATE 199 157
WARFARIN SODIUM 180 136
CITALOPRAM HBR 165 111
ATENOLOL 165 112
PLAVIX 149 132
RANITIDINE HCL 147 107
ATORVASTATIN CALCIUM 142 86
DIOVAN 133 89
GABAPENTIN 130 81
TRAMADOL HCL 126 77
PRAVASTATIN SODIUM 122 92
ZOLPIDEM TARTRATE 120 89
CYMBALTA 119 65
SERTRALINE HCL 99 33
ACTOS 99 56
METOPROLOL SUCCINATE 91 72
POTASSIUM CHLORIDE 89 75
GLIMEPIRIDE 88 43
ALENDRONATE SODIUM 88 75
ENALAPRIL MALEATE 86 63
NAMENDA 86 86
LANTUS 84 65
ADVAIR DISKUS 82 42
BACLOFEN 81 29
CLONIDINE HCL 77 65
DIGOXIN 76 66
NAPROXEN 76 54
PROAIR HFA 75 52
ALLOPURINOL 74 59
LYRICA 72 49
PREDNISONE 71 67
LIPITOR 70 56
LEVOFLOXACIN 69 54
SPIRONOLACTONE 67 54
FENOFIBRATE 66 26
PANTOPRAZOLE SODIUM 65 51
DEXILANT 63 0
DIOVAN HCT 63 37
SPIRIVA 61 48
FENTANYL 61 43 S2
FELODIPINE ER 60 37
FLUTICASONE PROPIONATE 59 39
ENDOCET 59 16 S2
TRICOR 58 29
FLUOXETINE HCL 56 53
NIASPAN 55 15
SINGULAIR 55 42
QUETIAPINE FUMARATE 55 31
LANSOPRAZOLE 50 25
JANUVIA 50 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.